TotalSeq™-C1072 anti-human IL-13 Antibody, IL-13, JES10-5A2,BioLegend,501921

ELISA or ELISPOT Capture1,2:The Ultra-LEAF™ Purified JES10-5A2 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated Poly5020 antibody (Cat. No. 502001) as the detecting antibody. The Ultra-LEAF™ Purified antibody is suggested for ELISPOT capture.

Host

Rat

Reactivity

Human

Application

ICPG - Quality tested

Platform ID

BAB177615377

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C1072 anti-human IL-13 Antibody, IL-13, JES10-5A2
Cat. No.501921
HostRat
IsotypeRat IgG1, κ
ReactivityHuman
ApplicationICPG - Quality tested
ClonalityMonoclonal
Clone NumberJES10-5A2
Concentration0.5 mg/mL
TargetIL-13
ImmunogenCOS-expressed, recombinant human IL-13
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

IL-13 is an immunoregulatory cytokine produced primarily by activated Th2 lymphocytes. IL-13 shares 30% amino acid sequence homology with IL-4 and demonstrates similar biological activities. The biological activities of IL-13 include: suppression of macrophage cytotoxic activity, upregulation of IL-1RA expression, and suppression of proinflammatory cytokine secretion. The JES10-5A2 antibody reacts with human interleukin-13 (IL-13). The JES10-5A2 antibody can neutralize the bioactivity of natural or recombinant IL-13.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.